Condition: Local Advanced High Risk Nasopharyngeal Carcinoma
Interventions: Drug: IMRT combine with cisplatin concurrent chemotherapy; Drug: IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy
Sponsor: Zhao Chong
Not yet recruiting - verified November 2016
http://ift.tt/2gcdMNe
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου